Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
Clinical trial NCT02790034 · TERMINATED
Trial details
- NCT number
- NCT02790034
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-26
- Primary completion
- 2019-08-06
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.